Army, Industry, International Partners Make Headway Against Leishmaniasis

Army, Industry, International Partners Make Headway Against Leishmaniasis

[author type="author"]Carey Phillips[/author] The U.S. Army Medical Research and Materiel Command (USMRMC) marked a major advance against the disease cutaneous leishmaniasis when the U.S. Food and Drug Administration (FDA) approved the marketing of a new diagnostic test developed by a partnership of the Walter Reed Army Institute of Research (WRAIR), the U.S. Army Medical Materiel Development Activity (USAMMDA), and the molecular diagnostics company Cepheid USA Inc. On the treatment front, USAMMDA continues to work with the Tunisian Ministry of Public Health and the Institute Pasteur of Tunis to develop the Paromomycin/Gentamicin Topical Cream for the treatment of cutaneous leishmaniasis. Because there is no topical treatment approved by the FDA, U.S. […]